Critical role of Kupffer cell CR3 (CD11b/CD18) in the clearance of IgM-opsonized erythrocytes or soluble β-glucan

被引:58
作者
Yan, J
Vetvicka, V
Xia, Y
Hanikyrová, M
Mayadas, TN
Ross, GD [1 ]
机构
[1] Univ Louisville, Dept Pathol, Div Expt Immunol & Immunopathol, Louisville, KY 40292 USA
[2] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40292 USA
[3] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[4] Harvard Univ, Sch Med, Boston, MA 02115 USA
来源
IMMUNOPHARMACOLOGY | 2000年 / 46卷 / 01期
关键词
complement; biological response modifier; clearance; macrophage; C3-receptor; liver;
D O I
10.1016/S0162-3109(99)00157-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Liver macrophages (Kupffer cells) play a major role in blood clearance of both C3-opsonized immune complexes and therapeutic beta-glucan polysaccharides, Human Kupffer cells express three types of C3-receptors: CR1 (C3b-receptor; CD35), CR3 (iC3b- and beta-glucan-receptor), and CR4 (iC3b-receptor; CD11c/CD18). Studies of isolated macrophages have suggested that CR3 is the major receptor mediating capture of either C3-opsonized erythrocytes (E) or beta-glucans. In this investigation, the organ distribution and function of CR3 in the clearance of IgM-opsonized E and soluble CR3-binding polysaccharides were explored in normal vs. CR3-knockout (CR3-KO) mice. Analysis of intravenously (i.v.) injected I-125-anti-CR3 showed that the major vascular reservoir of CR3 was the liver, followed by spleen and lungs. By contrast, clearance of I-125-anti-CR1 appeared to be mediated predominantly by splenic B lymphocytes, as only subsets of splenic macrophages or Kupffer cells were found to express CR1. Clearance of lgM-opsonized Cr-51-E occurred rapidly to the livers of normal mice but was nearly absent in CR3-KO mice. Soluble I-125-beta-glucan exhibited rapid clearance to the liver in normal mice, whereas clearance in CR3-KO mice was significantly reduced. In conclusion, Kupffer cell CR3 plays a crucial role in the clearance of both IgM-opsonized E and beta-glucans. (C) 2000 Published by Elsevier Science B.V. All rights resented.
引用
收藏
页码:39 / 54
页数:16
相关论文
共 82 条
[1]  
ABE S, 1984, GANN, V75, P459
[2]  
Adachi Y, 1998, BIOL PHARM BULL, V21, P278, DOI 10.1248/bpb.21.278
[3]  
ADACHI Y, 1994, BIOL PHARM BULL, V17, P1554, DOI 10.1248/bpb.17.1554
[4]  
ATKINSON J P, 1991, Clinical and Experimental Immunology, V86, P27
[5]   STUDIES ON INVIVO EFFECTS OF ANTIBODY - INTERACTION OF IGM ANTIBODY AND COMPLEMENT IN IMMUNE CLEARANCE AND DESTRUCTION OF ERYTHROCYTES IN MAN [J].
ATKINSON, JP ;
FRANK, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 54 (02) :339-348
[6]   EFFECT OF BACILLUS CALMETTE-GUERIN-INDUCED MACROPHAGE ACTIVATION ON INVIVO CLEARANCE OF SENSITIZED ERYTHROCYTES [J].
ATKINSON, JP ;
FRANK, MM .
JOURNAL OF CLINICAL INVESTIGATION, 1974, 53 (06) :1742-1749
[7]  
BENACERRAF B, 1964, LIVER, V2, P37
[8]   QUANTITATION, TISSUE DISTRIBUTION AND PROLIFERATION KINETICS OF KUPFFER CELLS IN NORMAL RAT-LIVER [J].
BOUWENS, L ;
BAEKELAND, M ;
DEZANGER, R ;
WISSE, E .
HEPATOLOGY, 1986, 6 (04) :718-722
[9]  
BROWN DL, 1970, CLIN EXP IMMUNOL, V7, P401
[10]   ROLE OF COMPLEMENT RECEPTOR TYPE 3 AND SERUM OPSONINS IN THE NEUTROPHIL RESPONSE TO YEAST [J].
CAIN, JA ;
NEWMAN, SL ;
ROSS, GD .
COMPLEMENT, 1987, 4 (02) :75-86